Amgen has announced it is developing its already marketed psoriasis drug Otezla as a potential treatment for COVID-19, the respiratory disease caused by the SARS-CoV-2 coronavirus. Otezla ...

Amgen has won FDA approval for a stronger label for its oral plaque psoriasis therapy Otezla, as it prepares for competition from Bristol-Myers Squibb's much-touted rival deucravacitinib ...

The Ned Otezla commercial features a man gaining confidence to go on a date despite his plaque psoriasis, thanks to Otezla ...

No nail changes were noted. His grandfather has a history of psoriasis. Small, drop-like, salmon-pink, 1 mm to 10 mm papules with a fine scale (see Figure 1). Guttate psoriasis mainly affects the ...